Table 1.
Demographic, Clinical, and Medication Variables in the IPS and CVR Groups
| IPS (n=28) |
CVR (n=22) |
t or χ2 (df) | p | |
|---|---|---|---|---|
| Age in Years (Mean, [SD]) | 50.0 (3.2) | 51.1 (5.0) | 0.95 (34.1) | .323 |
| Education in Years (Mean, [SD]) | 12.4 (2.4) | 12.4 (2.6) | 0.00 (48) | .993 |
| Gender, % male | 71 | 46 | 3.46 (1) | .063 |
| Ethnicity, % minority | 36 | 36 | 0.00 (1) | .962 |
| Diagnosis, % schizophrenia (vs. schizoaffective) |
50 | 27 | 2.65 (1) | .103 |
| Duration of illness | 25.0 (10.3) | 22.3 (11.3) | 0.74 (48) | .463 |
| Antipsychotic medication dose in CPZE | 401.7 (449.6) | 252.0 (277.9) | 1.36 (46) | .182 |
| PANSS positive symptoms | 15.9 (4.3) | 14.5 (6.5) | 0.86 (41) | .394 |
| PANSS negative symptoms | 15.3 (5.3) | 16.6 (5.1) | 0.81 (41) | .424 |
| HAM-D depressive symptoms | 9.8 (6.7) | 11.8 (8.6) | 0.82 (40) | .416 |
| AIMS tardive dyskinesia severity | 2.1 (2.8) | 2.4 (3.7) | 0.25 (39) | .805 |
| Quality of Life Interview Global Satisfaction Index |
4.3 (1.6) | 4.1 (1.6) | 0.43 (40) | .673 |
| Years since last job | 6.5 (7.4) | 7.8 (6.2) | 0.68 (47) | .497 |
| Monthly disability entitlement income, dollars |
807.4 (272.7) | 772.2 (143.4) | 0.54 (47) | .594 |